Nonlinear effects and effect modification at the participant-level in IPD meta-analysis part 2: methodological guidance is available
- PMID: 37146657
- PMCID: PMC7616838
- DOI: 10.1016/j.jclinepi.2023.04.014
Nonlinear effects and effect modification at the participant-level in IPD meta-analysis part 2: methodological guidance is available
Abstract
Objectives: To review methodological guidance for nonlinear covariate-outcome associations (NL), and linear effect modification and nonlinear effect modification (LEM and NLEM) at the participant level in individual participant data meta-analyses (IPDMAs) and their power requirements.
Study design and setting: We searched Medline, Embase, Web of Science, Scopus, PsycINFO and the Cochrane Library to identify methodology publications on IPDMA of LEM, NL or NLEM (PROSPERO CRD42019126768).
Results: Through screening 6,466 records we identified 54 potential articles of which 23 full texts were relevant. Nine further relevant publications were published before or after the literature search and were added. Of these 32 references, 21 articles considered LEM, 6 articles NL or NLEM and 6 articles described sample size calculations. A book described all four. Sample size may be calculated through simulation or closed form. Assessments of LEM or NLEM at the participant level need to be based on within-trial information alone. Nonlinearity (NL or NLEM) can be modeled using polynomials or splines to avoid categorization.
Conclusion: Detailed methodological guidance on IPDMA of effect modification at participant-level is available. However, methodology papers for sample size and nonlinearity are rarer and may not cover all scenarios. On these aspects, further guidance is needed.
Keywords: Effect modification; Fractional polynomials; Individual participant data meta-analysis; Interaction; Methodology; Nonlinear; One- and two-stage models; Restricted cubic splines; Sample size.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests.
References
-
- Riley RD, Debray TPA, Fisher D, Hattle M, Marlin N, Hoogland J, et al. Individual participant data meta-analysis to examine interactions between treatment effect and participant-level covariates: statistical recommendations for conduct and planning. Stat Med. 2020;39:2115–37. doi: 10.1002/sim.8516. - DOI - PMC - PubMed
-
- Tierney JF, Stewart LA, Clarke M. In: Cochrane handbook for systematic reviews of interventions version 63. Higgins JPT, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane; 2022. [Accessed June 12, 2023]. Chapter 26: individual participant data. (updated February 2022) Available at www.training.cochrane.org/handbook.
-
- Schandelmaier S, Briel M, Varadhan R, Schmid CH, Devasenapathy N, Hayward RA, et al. Development of the instrument to assess the credibility of effect modification analyses (ICEMAN) in randomized controlled trials and meta-analyses. CMAJ. 2020;192(32):E901–6. doi: 10.1503/cmaj.200077. - DOI - PMC - PubMed
-
- Marlin N, Allotey J. The difference between effect modification and covariate confounding. BJOG. 2021;128:1574. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources